Morrell Martha 4

What Happened Martha Morrell, Chief Medical Officer of NeuroPace (NPCE), had 358 shares withheld by the company to satisfy tax withholding obligations related to the vesting of restricted stock units. The withholding occurred on February 27, 2026 at an effective per-share amount of $14.58, for a total value of approximately $5,220. This was a tax-withholding disposition (not an open-market sale).

Key Details

• Transaction date: 2026-02-27
• Transaction type/code: F (shares withheld to satisfy tax withholding on RSU vesting)
• Shares withheld/disposed: 358 shares at $14.58 per share — total ~$5,220
• Shares owned after transaction: Not specified in the provided filing excerpt
• Footnote: F1 — issuer withheld these shares on Feb 27, 2026 to satisfy tax withholding tied to RSU vesting
• Filing timeliness: Report filed 2026-03-02 (timely relative to the Form 4 reporting window)

Context Tax-withholding share dispositions are routine when restricted stock units vest: the company retains (or "sells back") enough shares to cover required taxes rather than the insider selling shares on the open market. Such transactions reduce the number of shares issued to the insider but generally are not interpreted as a directional buy/sell signal about the insider’s view of the company.